Fuji Pharma Co.,Ltd.
Specializes in hormone medicines for ob/gyn, injectables, and contract manufacturing.
4554 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 千代田区三番町５番地７
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Fuji Pharma Co., Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and marketing of pharmaceutical products for medical use. The company specializes in hormone medicines, particularly for obstetrics and gynecology, and injectable drugs. Its portfolio also includes internal drugs, external use medications, and diagnostic products. In addition to its proprietary products, Fuji Pharma offers a wide range of contract manufacturing services for various formulations, including solids, injections, ointments, creams, and liquids. The company is noted for its extensive experience and specialized quality containment technology in the production of hormone-based pharmaceuticals.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Fuji Pharma Co.,Ltd. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-09 04:10 |
Regulatory News Service
確認書
|
Japanese | 8.7 KB | |
| 2025-05-09 04:09 |
Interim Report
半期報告書－第61期(2024/10/01－2025/09/30)
|
Japanese | 216.6 KB | |
| 2024-12-23 04:46 |
Regulatory News Service
臨時報告書
|
Japanese | 25.0 KB | |
| 2024-12-23 04:37 |
Regulatory News Service
確認書
|
Japanese | 8.7 KB | |
| 2024-12-23 04:33 |
Regulatory News Service
内部統制報告書－第60期(2023/10/01－2024/09/30)
|
Japanese | 23.3 KB | |
| 2024-12-23 04:32 |
Annual Report
有価証券報告書－第60期(2023/10/01－2024/09/30)
|
Japanese | 1.7 MB | |
| 2024-07-18 09:11 |
Prospectus
有価証券届出書（参照方式）
|
Japanese | 285.7 KB | |
| 2024-05-10 07:27 |
Quarterly Report
四半期報告書－第60期第2四半期(2024/01/01－2024/03/31)
|
Japanese | 216.0 KB | |
| 2024-05-10 07:27 |
Regulatory News Service
確認書
|
Japanese | 8.6 KB | |
| 2024-02-09 08:20 |
Regulatory News Service
確認書
|
Japanese | 8.7 KB | |
| 2024-02-09 08:19 |
Quarterly Report
四半期報告書－第60期第1四半期(2023/10/01－2023/12/31)
|
Japanese | 178.7 KB | |
| 2023-12-21 07:28 |
Regulatory News Service
臨時報告書
|
Japanese | 27.9 KB | |
| 2023-12-21 07:26 |
Regulatory News Service
確認書
|
Japanese | 8.7 KB | |
| 2023-12-21 07:25 |
Regulatory News Service
内部統制報告書－第59期(2022/10/01－2023/09/30)
|
Japanese | 23.3 KB | |
| 2023-12-21 07:23 |
Annual Report
有価証券報告書－第59期(2022/10/01－2023/09/30)
|
Japanese | 1.6 MB |
Automate Your Workflow. Get a real-time feed of all Fuji Pharma Co.,Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Fuji Pharma Co.,Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
